Why the study?
Does intravenous lorcainide alter electrophysiological parameters and terminate ventricular tachycardia in patients with pre-excitation or conduction disturbances?
Population
23 patients with atrioventricular conduction disturbances, ventricular tachycardia, and accessory…
Design
Case_series
Authors
Loading...
May terminate VT in pre-excitation; hypothesis-generating and advises avoidance in bundle-branch block.
Does intravenous lorcainide alter electrophysiological parameters and terminate ventricular tachycardia in patients with pre-excitation or conduction disturbances?
Intravenous lorcainide prolongs the HV interval and accessory pathway refractory period, and can terminate ventricular tachycardia, but should be avoided in patients with bundle-branch block.
Bär et al. (1981) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: